SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-007977
Filing Date
2014-02-06
Accepted
2014-02-06 15:52:03
Documents
1
Period of Report
2014-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15934
  Complete submission text file 0001209191-14-007977.txt   17589
Mailing Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000
Business Address C/O NOVARTIS INTERNATIONAL AG WSJ-200.220 CH-4002 BASEL V8 0000000000 41-61-324-6210
Novartis Bioventures Ltd (Reporting) CIK: 0001297709 (see all company filings)

State of Incorp.: D0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36183 | Film No.: 14580027

Mailing Address 12760 HIGH BLUFF DRIVE SUITE 240 SAN DIEGO CA 92130
Business Address 12760 HIGH BLUFF DRIVE SUITE 240 SAN DIEGO CA 92130 858-366-4288
Celladon Corp (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 330971591 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)